Your browser doesn't support javascript.
loading
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine.
De Pas, T; de Braud, F; Mandalà, M; Curigliano, G; Catania, C; Ferretti, G; Sozzi, P; Solli, P; Goldhirsch, A.
Affiliation
  • De Pas T; Divisions of Medical Oncology, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy. tommaso.de-pas@ieo.it
Lung Cancer ; 31(2-3): 267-70, 2001.
Article in En | MEDLINE | ID: mdl-11165406
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Vinblastine / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Neoplasm Recurrence, Local / Antineoplastic Agents, Phytogenic Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2001 Type: Article Affiliation country: Italy
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Vinblastine / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Neoplasm Recurrence, Local / Antineoplastic Agents, Phytogenic Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2001 Type: Article Affiliation country: Italy